The role of food peptides in lipid metabolism during dyslipidemia and associated health conditions

International Journal of Molecular Sciences

Volumn 16, Issue 5, 2015, Pages 9303-9313

  Udenigwe, Chibuike C ^a   Rouvinen Watt, Kirsti ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adipose tissue; Bioactive peptides; Cardiovascular disease; Hepatic steatosis; Hepatocytes; Hyperlipidemia; Lipogenesis; Metabolic syndrome

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A OXIDASE; ADIPONECTIN RECEPTOR; ARGININE; CARNITINE PALMITOYLTRANSFERASE 2; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; DOPAMINE RECEPTOR; FAS ANTIGEN; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; FATTY ACID TRANSPORTER 4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALATE DEHYDROGENASE (DECARBOXYLATING); MESSENGER RNA; NEUROTENSIN; NITRIC OXIDE; PEPSIN A; PEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN HYDROLYSATE; STEROL 14ALPHA DEMETHYLASE; THIOL ESTER HYDROLASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTILIPEMIC AGENT; CHOLESTEROL INTAKE; LIPID; PROTEIN INTAKE; TRANSCRIPTION FACTOR;

ADIPOCYTE; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DYSLIPIDEMIA; ESCHERICHIA COLI; FATTY LIVER; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOLIPEMIA; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; LIVER FUNCTION; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; CHEMISTRY; CHOLESTEROL INTAKE; CYTOLOGY; DIET; INTESTINE ABSORPTION; METABOLISM; MOUSE; PROTEIN INTAKE;

ANIMALIA;

ADIPOCYTES; ANIMALS; CHOLESTEROL, DIETARY; DIET; DIETARY PROTEINS; DYSLIPIDEMIAS; HEPATOCYTES; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INTESTINAL ABSORPTION; LIPID METABOLISM; LIPIDS; METABOLIC SYNDROME X; MICE; PEPTIDES; TRANSCRIPTION FACTORS;

EID: 84928407675     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16059303     Document Type: Review

References (38)

1. Malik, V.S.; Willett, W.C.; Hu, F.B. Global obesity: Trends, risk factors and policy implications. Nat. Rev. Endocrinol. 2013, 9, 13–27.
2. Cornier, M.A.; Dabelea, D.; Hernandez, T.L.; Lindstrom, R.C.; Steig, A.J.; Stob, N.R.; van Pelt, R.E.; Wang, H.; Eckel, R.H. The metabolic syndrome. Endocr. Rev. 2008, 29, 777–822.
3. Misra, A.; Khurana, L. Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 2008, 93, S9–S30.
4. WHO (World Health Organization). World Health Statistics; Geneva, Switzerland, 2012.
5. Roberts, C.K.; Sindhu, K.K. Oxidative stress and metabolic syndrome. Life Sci. 2009, 84, 705–712.
6. Abete, I.; Goyenechea, E.; Zulet, M.A.; Martíneza, J.A. Obesity and metabolic syndrome: Potential benefit from specific nutritional components. Nutr. Metab. Cardiovasc. Dis. 2011, 21, B1–B15.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc. 2001, 285, 2486–2497.
8. Sirtori, C.R.; Galli, C.; Anderson, J.W.; Arnoldi, A. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins. Atherosclerosis 2009, 203, 8–17.
9. Wanezaki, S.; Tachibana, N.; Nagata, M.; Saito, S.; Nagao, K.; Yanagita, T.; Kohno, M. Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease. Obes. Res. Clin. Pract. 2015, 9, 168–174.
10. Nagata, Y.; Noguchi, Y.; Tamaru, S.; Kuwahara, K.; Okamoto, A.; Suruga, K.; Koba, K.; Tanaka, K. Hypolipidemic potential of squid homogenate irrespective of a relatively high content of cholesterol. Lipids Health Dis. 2014, 13, 165, doi:10.1186/1476-511X-13-165.
11. Vik, R.; Bjørndal, B.; Bohov, P.; Brattelid, T.; Svardal, A.; Nygård, O.K.; Nordrehaug, J.E.; Skorve, J.; Berge, R.K. Hypolipidemic effect of dietary water-soluble protein extract from chicken: Impact on genes regulating hepatic lipid and bile acid metabolism. Eur. J. Nutr. 2015, 54, 193–204.
12. Chen, Q.; Wood, C.; Gagnon, C.; Cober, E.R.; Frégeau-Reid, J.A.; Gleddie, S.; Xiao, C.W. The α' subunit of β-conglycinin and the A1–5 subunits of glycinin are not essential for many hypolipidemic actions of dietary soy proteins in rats. Eur. J. Nutr. 2014, 53, 1195–1207.
13. Rodríguez-Figueroa, J.C.; González-Córdova, A.F.; Astiazaran-García, H.; Hernández-Mendoza, A.; Vallejo-Cordoba, B. Antihypertensive and hypolipidemic effect of milk fermented by specific Lactococcus lactis strains. J. Dairy Sci. 2013, 96, 4094–4099.
14. Bähr, M.; Fechner, A.; Kiehntopf, M.; Jahreis, G. Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: A randomized controlled trial. Clin. Nutr. 2015, 34, 7–14.
15. Navab, M.; Anantharamaiah, G.M.; Reddy, S.T.; Hama, S.; Hough, G.; Frank, J.S.; Grijalva, V.R.; Ganesh, V.K.; Mishra, V.K.; Palgunachari, M.N.; et al. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. Circ. Res. 2005, 97, 524–532.
16. Lillefosse, H.H.; Tastesen, H.S.; Du, Z.Y.; Ditlev, D.B.; Thorsen, F.A.; Madsen, L.; Kristiansen, K.; Liaset, B. Hydrolyzed casein reduces diet-induced obesity in male C57BL/6J mice. J. Nutr. 2013, 143, 1367–1375.
17. Ikeda, K.; Kitagawa, S.; Tada, T.; Iefuji, H.; Inoue, Y.; Izawa, S. Modification of yeast characteristics by soy peptides: Cultivation with soy peptides represses the formation of lipid bodies. Appl. Microbiol. Biotechnol. 2011, 89, 1971–1977.
18. Howard, A.; Udenigwe, C.C. Mechanisms and prospects of food protein hydrolysates and peptide-induced hypolipidaemia. Food Funct. 2013, 4, 40–51
19. González-Ortega, O.; López-Limón, A.R.; Morales-Domínguez, J.F.; Soria-Guerra, R.E. Production and purification of recombinant hypocholesterolemic peptides. Biotechnol. Lett. 2015, 37, 41–54.
20. Ktari, N.; Mnafgui, K.; Nasri, R.; Hamden, K.; Bkhairia, I.; Hadj, A.B.; Boudaouara, T.; Elfeki, A.; Nasri, M. Hypoglycemic and hypolipidemic effects of protein hydrolysates from zebra blenny (Salaria basilisca) in alloxan-induced diabetic rats. Food Funct. 2013, 4, 1691–1699.
21. Kapravelou, G.; Martínez, R.; Andrade, A.M.; Sánchez, C.; Chaves, C.L.; López-Jurado, M.; Aranda, P.; Cantarero, S.; Arrebola, F.; Fernández-Segura, E.; et al. Health promoting effects of Lupin (Lupinus albus var. multolupa) protein hydrolyzate and insoluble fiber in a diet-induced animal experimental model of hypercholesterolemia. Food Res. Int. 2013, 54, 1471–1481.
22. Malinin, V.V.; Savateeva-Lyubimova, T.N.; Sivak, K.V. Hypolipidemic and hypoglycemic effect of peptide Lys-Glu-Trp-NH2 in rats with associated metabolic disorders. Bull. Exp. Biol. Med. 2014, 156, 338–341.
23. Zhang, H.; Bartley, G.E.; Zhang, H.; Jing, W.; Fagerquist, C.K.; Zhong, F.; Yokoyama, W. Peptides identified in soybean protein increase plasma cholesterol in mice on hypercholesterolemic diets. J. Agric. Food Chem. 2013, 61, 8389–8395.
24. Martinez-Villaluenga, C.; Rupasinghe, S.G.; Schuler, M.A.; Gonzalez de Mejia, E. Peptides from purified soybean β-conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain. FEBS J. 2010, 277, 1481–1493.
25. Jia, Y.; Kim, J.H.; Nam, B.; Kim, J.; Lee, J.H.; Hwang, K.Y.; Lee, S.J. The dipeptide H-Trp-Glu-OH (WE) shows agonistic activity to peroxisome proliferator-activated protein-α and reduces hepatic lipid accumulation in lipid-loaded H4IIE cells. Bioorg. Med. Chem. Lett. 2014, 24, 2957–2962.
26. Yamada, Y.; Muraki, A.; Oie, M.; Kanegawa, N.; Oda, A.; Sawashi, Y.; Kaneko, K.; Yoshikawa, M.; Goto, T.; Takahashi, N.; et al. Soymorphin-5, a soy-derived μ-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARα systems in diabetic KKAy mice. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E433–E440.
27. Yamauchi, R.; Ohinata, K.; Yoshikawa, M. β-Lactotensin and neurotensin rapidly reduce serum cholesterol via NT 2 receptor. Peptides 2003, 24, 1955–1961.
28. Lu, K.; Lee, M.H.; Patel, S.B. Dietary cholesterol absorption; more than just bile. Trends Endocrinol. Metab. 2001, 12, 314–320.
29. Marques, M.R.; Freitas, R.A.M.S.; Carlos, A.C.C.; Siguemoto, É.S.; Fontanari, G.G.; Arêas, J.A.G. Peptides from cowpea present antioxidant activity, inhibit cholesterol synthesis and its solubilisation into micelles. Food Chem. 2015, 168, 288–293.
30. Matsuoka, R.; Shirouchi, B.; Kawamura, S.; Baba, S.; Shiratake, S.; Nagata, K.; Imaizumi, K.; Sato, M. Dietary egg white protein inhibits lymphatic lipid transport in thoracic lymph duct-cannulated rats. J. Agric. Food Chem. 2014, 62, 10694–10700.
31. Udenigwe, C.C. Bioinformatics approaches, prospects and challenges of food bioactive peptide research. Trends Food Sci. Technol. 2014, 36, 137–143.
32. De Mejia, E.G.; Martinez-Villaluenga, C.; Roman, M.; Bringe, N.A. Fatty acid synthase and in vitro adipogenic response of human adipocytes inhibited by α and α' subunits of soybean β-conglycinin hydrolysates. Food Chem. 2010, 119, 1571–1577.
33. Goto, T.; Mori, A.; Nagaoka, S. Soluble soy protein peptic hydrolysate stimulates adipocyte differentiation in 3T3-L1 cells. Mol. Nutr. Food Res. 2013, 57, 1435–1445.
34. Liaset, B.; Hao, Q.; Jørgensen, H.; Hallenborg, P.; Du, Z.Y.; Ma, T.; Marschall, H.U.; Kruhøffer, M.; Li, R.; Li, Q.; et al. Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome. J. Biol. Chem. 2011, 286, 28382–28395.
35. Lammi, C.; Zanoni, C.; Scigliuolo, G.M.; D’Amato, A.; Arnoldi, A. Lupin peptides lower low-density lipoprotein (LDL) cholesterol through an up-regulation of the LDL receptor/sterol regulatory element binding protein 2 (SREBP2) pathway at HepG2 cell line. J. Agric. Food Chem. 2014, 62, 7151–7159.
36. Yamazaki, T.; Kishimoto, K.; Miura, S.; Ezaki, O. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein. J. Nutr. Biochem. 2012, 23, 123–132.
37. Ye, F.; Zhang, Z.S.; Luo, H.B.; Shen, J.H.; Chen, K.X.; Shen, X.; Jiang, H.L. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARγ: Bioassay with molecular modeling simulation. ChemBioChem 2006, 7, 74–82.
38. Inoue, N.; Nagao, K.; Sakata, K.; Yamano, N.; Gunawardena, P.E.R.; Han, S.Y.; Matsui, T.; Nakamori, T.; Furuta, H.; Takamatsu, K.; et al. Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivo. Lipids Health Dis. 2011, 10, 85, doi:10.1186/1476-511X-10-85.